Wall Street analysts have significantly lowered their 2026 revenue projections for Aquestive Therapeutics (AQST) by 26%, signaling heightened caution even as the stock price climbs. The revised forecasts highlight a more conservative view of the company's near-term growth trajectory.
The industry's premier Ride & Drive event in Indianapolis will offer fleet managers hands-on experience with the latest Class 2-7 electric trucks, vans, and advanced internal combustion models, highlighting a pivotal moment for commercial transportation.
Wabash National Corporation reported fourth-quarter revenue that surpassed Wall Street expectations, yet a sharp year-over-year sales decline and a disappointing forward outlook triggered a significant sell-off, highlighting ongoing challenges in the freight and industrial sectors.
As the TSX's fourth-quarter earnings season unfolds with strength, income-focused investors are turning to dividend payers for reliable returns. We examine three Canadian companies with robust fundamentals and yields up to 4.7%.
The Reserve Bank of India is fundamentally reshaping its oversight of lenders, moving beyond traditional financial metrics to scrutinize the actual business practices and credit management processes within banks.
GSK reported robust full-year 2025 results, with sales exceeding £32 billion and profit growth outpacing revenue. Executives outlined a 2026 strategy focused on maximizing recent drug launches, accelerating late-stage pipeline assets, and leveraging technology, while navigating currency headwinds and a profit shift to the second half.
Reynolds Consumer Products (NASDAQ: REYN) reported fourth-quarter sales that surpassed analyst expectations, though a weaker-than-anticipated revenue forecast for the coming quarter highlights ongoing challenges in volume growth for the household staples maker.
The industrial toolmaker reported flat year-over-year sales of $3.68 billion for Q4 2025, missing analyst estimates, though adjusted earnings per share of $1.41 came in nearly 10% above forecasts. The mixed results highlight ongoing challenges in a dynamic market.
Novo Nordisk's stock tumbled sharply after the Danish pharmaceutical giant issued a weaker-than-expected forecast for 2026, citing pricing deals and competitive threats to its blockbuster weight-loss drugs.
The search for Savannah Guthrie's 84-year-old mother, Nancy, enters its fourth day with the disturbing emergence of purported ransom notes sent to media outlets, as authorities investigate signs of a forced entry at her Tucson home.
Morgan Stanley's robust fourth-quarter performance, led by a resurgent investment banking division and stable wealth management, has reignited investor interest and sparked fresh analysis on whether its current stock price fully reflects future prospects.
The New York Times Company (NYSE: NYT) reported fourth-quarter revenue of $802.3 million, a 10.4% year-over-year increase that surpassed analyst expectations. While adjusted earnings per share met consensus, the results highlight both the strength of its digital transition and ongoing challenges in monetizing its growing subscriber base.
Johnson Controls International (NYSE: JCI) reported fourth-quarter results that exceeded analyst expectations, with revenue climbing 6.8% year-over-year to $5.80 billion. Adjusted earnings per share of $0.89 also topped estimates, sending the stock sharply higher.
WeRide's stock has plummeted 48% over the past year, leaving investors to grapple with a stark contradiction: a DCF model suggests massive undervaluation, while its sky-high P/S ratio screams overvaluation. We examine the numbers, the narrative, and what it means for the autonomous driving pioneer's future.
Mondelez International merges its financial and operational command under longtime CFO Luca Zaramella, signaling a strategic push for tighter alignment between profit goals and on-the-ground execution amid market pressures.
Oaktree Specialty Lending (OCSL) reported fourth-quarter revenue in line with Wall Street expectations at $75.1 million, though sales declined 13.3% year-over-year. Non-GAAP earnings per share of $0.06 fell sharply below analyst consensus, highlighting challenges in the current lending environment.
After a challenging 2025, e.l.f. Beauty's stock saw a significant rebound last month, driven by favorable tariff adjustments and growing sentiment that the market may have undervalued the resilient cosmetics disruptor.
A young man with a substantial net worth seeks advice on pursuing his music dreams. Dave Ramsey and his team weigh the balance between financial security and artistic passion in a tough economic climate.
Avery Dennison (NYSE: AVY) reported fourth-quarter revenue of $2.27 billion, a 3.9% year-over-year increase that fell short of Wall Street expectations. However, adjusted earnings per share of $2.45 surpassed consensus estimates by 2.9%, highlighting a quarter of resilient profitability amid challenging market conditions.
Independent investment bank Evercore (NYSE: EVR) delivered a powerful finish to 2025, with Q4 revenue soaring 31.4% to $1.29B, significantly outperforming Wall Street expectations. Adjusted EPS of $5.13 also beat consensus estimates by a wide margin.
